HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno. N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s Sciwind Biosciences.
Search results for "diabetes drug"
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight." This is a common phrase heard when visiting a hospital for knee pain. As weight increases, the burden on the knee joints...
Restoring the Breath of Night: The Potential for a Sleep Apnea Pill
Obstructive sleep apnea , a condition where breathing repeatedly stops during sleep, is far more than a mere snoring...
GLP-1 Drugs and Bone Health: Studies Highlight Fracture Risks in Elderly Patients
The GLP-1 receptor agonist class of drugs, widely used for the treatment of obesity and type 2 diabetes, has...
The Eye Supplement Myth: Is Lutein and Vitamin A Really Necessary for Your Vision?
"In the past, many people lost their vision because we lacked specialized treatments for ophthalmic diseases.
Statins: Are the Side Effects Real? New Research Challenges Common Fears
"Many people hesitate to take cholesterol medication because of side effects they’ve heard about through the...
Why ‘Elegant Dining’ Might Be the Secret to Appetite Control
If you typically rush through a sandwich at your desk or eat in a chaotic environment, you might be missing out on a...
Does Mounjaro Harm Eye Health? Long-Term Study Shows Diabetic Retinopathy Risk Actually Drops
Concerns that Eli Lilly’s popular weight-loss and diabetes treatment, Mounjaro, might exacerbate eye complications in...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...